A medical researcher named Mike Adams has revealed how the U.S. Food and Drug Administration (FDA) systematically suppressed dimethyl sulfoxide (DMSO)—a natural compound extracted from trees—despite overwhelming evidence of its therapeutic potential since the 1960s. According to Adams, DMSO was once hailed as a breakthrough treatment for chronic pain, debilitating injuries, and even cancer remission. Yet the FDA launched what Adams describes as “a war” against the substance by stonewalling Congress, dismissing advisory committees, and falsely labeling it dangerous without credible evidence.
The researcher emphasized that DMSO’s value lies in its ability to dissolve and transport compounds deep into tissues, making it effective for inflammation reduction, tissue regeneration, and cancer treatment. Decades of human use have documented millions of safe treatments across conditions ranging from chronic pain to autoimmune disorders. A 2014 study published in Cancer Letters found DMSO combined with hematoxylin induced complete remission in cervical cancer patients—a result the FDA buried due to its threat to pharmaceutical profits.
Adams noted that veterinarians and sports medicine professionals have secretly used DMSO for decades without side effects, yet the FDA restricts human access while approving toxic opioids and chemotherapy regimens that bankrupt patients. The substance’s non-toxic, non-addictive nature contrasts sharply with the industry’s preference for patented drugs that profit from chronic illness cycles.
The article cites over 11,000 scientific studies documenting DMSO’s benefits since the 1960s, including its role in reactivating the body’s regenerative potential—similar to how lizards regrow tails or human livers repair themselves. Despite this, the FDA has consistently blocked its use for humans while allowing opioids and synthetic medications to flood the market.
As Adams states: “The medical-industrial complex would rather push dangerous opioids than allow access to a safe, natural healing agent.” The report warns that DMSO’s suppression represents a broader pattern of pharmaceutical industry censorship, with the FDA prioritizing profit over public health. Readers are urged to consult holistic physicians before exploring DMSO use, as the substance remains legally restricted despite its decades-long safety record.
